|
|
Post by peppy on Mar 6, 2017 13:49:06 GMT -5
we know the reverse split did not come from a position of financial strength. The strength is Afrezza insulin works better than subq fast acting. The physicians? The world can see afrezza works well on the monitors, so what really is going on here? David and Goliath. The world actually isn't watching any of those monitors. The people following those users' posting CGM screens are us and basically no one else. which is ridiculous. The physicians know. they see people with the continuous glucose monitors. like these physicians can not see.
dream boat, like the chemical trials in the skies in my back yard. I have a million pictures of on my Iphone, above our heads and people do not comment. we are not blind we can see but heads are buried.
|
|
|
|
Post by cjm18 on Mar 6, 2017 13:55:25 GMT -5
He did? I thought he wanted the 1-10. Tell me more:-) "First off, even if the stock has not managed to get back over $1 and stay there long enough in time to meet the criteria to avoid delisting, the company can file for another six-month extension (and such petitions are almost always granted), or, alternatively, the company could guarantee the stock price would be over $1 by simply convincing shareholders to approve a reverse split of the stock." www.notwallstreet.com/mannkind-mnkd-12717/ |
|
|
|
Post by sportsrancho on Mar 6, 2017 13:55:33 GMT -5
This is what happens with a RS. And you're right it hasn't failed yet. I don't think it will go below 1.30 It would be nice if you had some technical analysis or historical data regarding reverse splits supporting this $1.3 low thesis. I think I'll just imagine you do rather than asking and risk disappointment  Its just personal experience. IMO they tend to lose almost half their value. Then come right back up and hang out there until some good or bad news or earnings. |
|
|
|
Post by seanismorris on Mar 6, 2017 13:58:54 GMT -5
Nate was nuts buying pre RS. Recommending doing so in his newsletter screams AMATEUR.
I, myself am an amateur and even I know that much...
There is an opportunity to trade MNKD here. The problem is without clarity from management, I and everyone else would be taking an enormous risk doing so.
The stock is tanking because there are no buyers. There are no buyers because we expect further dilution. Also, raising additional funds may be impossible.
Add that to the fact buyers are out of ammo, and low on trust... and you get MNKD's current stock price.
Any technicals that may tell us to buy have to be ignored in this situation.
--- I also thought 1:5 split was a head scratcher. On one hand, MNKD wasn't going to get to $5, on the other hand why not put a larger bufffer between $1?
We can only hope management has something in the works that justifies going with the 1:5.
Until we hear from management, MNKD is an avoid stock.
|
|
|
|
Post by victoria on Mar 6, 2017 14:00:19 GMT -5
Hello all. I am still here: its a good product which is why I remain invested, but we need those sales now. Stating the obvious I know.
My investment - which of course I always knew I could lose - has gone from 6 figures to 4 as of today.... Regrettably (gut feeling only) we may well find this is pushed below $1 on one day by closing time in the next several days. It just looks like a soft target if a rival wants to drive it into delisting territory for commercial reasons by pushing it back into sub $1 territory. We need sales-related developments (of the good kind), swiftly. Or a significant buyout of some rights (hope springs eternal).
|
|
|
|
Post by avi8torslc on Mar 6, 2017 14:03:06 GMT -5
no one expected an extension....getting close to adding more
|
|
|
|
Post by cjm18 on Mar 6, 2017 14:05:55 GMT -5
no one expected an extension....getting close to adding more The poll on here had 60% expecting it. |
|
|
|
Post by sportsrancho on Mar 6, 2017 14:08:06 GMT -5
Hello all. I am still here: its a good product which is why I remain invested, but we need those sales now. Stating the obvious I know. My investment - which of course I always knew I could lose - has gone from 6 figures to 4 as of today.... Regrettably (gut feeling only) we may well find this is pushed below $1 on one day by closing time in the next several days. It just looks like a soft target if a rival wants to drive it into delisting territory for commercial reasons by pushing it back into sub $1 territory. We need sales-related developments (of the good kind), swiftly. Or a significant buyout of some rights (hope springs eternal). Good to see you:-) I'm guessing Matt will find a way to make the money last until the end of the year. That's gives us some time for advertising. If we start now! I'll give things to July to head in the right direction. |
|
|
|
Post by kc on Mar 6, 2017 14:09:07 GMT -5
Not fun to watch this happen. I just hope one day in the near future something cataclysmic occurs and we vaporize all the shorts. Come on Board of Directors Sell the company and destroy the evil demons (shorts) that have robbed us of our potential return on MannKind. MannKind needs capital and that will only happen if the company is sold somebody who can properly monetize Afrezza.
|
|
|
|
Post by peppy on Mar 6, 2017 14:09:37 GMT -5
stupid poll. I did not vote.
|
|
|
|
Post by peppy on Mar 6, 2017 14:11:17 GMT -5
Not fun to watch this happen. I just hope one day in the near future something cataclysmic occurs and we vaporize all the shorts. Come on Board of Directors Sell the company and destroy the evil demons (shorts) that have robbed us of our potential return on MannKind. MannKind needs capital and that will only happen if the company is sold somebody who can properly monetize Afrezza. Like Mannkind announces Damon show on NBC this summer and we get sales?
Lizzy is wishing on a star now.
|
|
|
|
Post by dreamboatcruise on Mar 6, 2017 14:13:23 GMT -5
no one expected an extension....getting close to adding more The poll on here had 60% expecting it. He probably meant "no one with full mental capacities intact". As we know, most of us here on proboards suffer from severe MNKD induced PTSD. BTW... I declined to vote as I didn't feel I understood the rules well enough to have an informed opinion. |
|
|
|
Post by seanismorris on Mar 6, 2017 14:15:25 GMT -5
Delisting isn't really a concern right now. What we are worried about is perceptions, and what management was thinking, and what they are doing.
The odds of surviving 6 months, with what we know today, I figure to be 10%.
Management needs to speak to change that perception, otherwise Shorts and going to continue to dominate (and rightly so).
When I listened to the last CC, I heard defeat in their voices. Shorts listened to the call, and smelled blood in the water.
Sharks have very good senses... and they are swarming. Unless you have a really big spear, don't jump in the water.
MNKD has reduced my spear to a toothpick...
|
|
|
|
Post by kc on Mar 6, 2017 14:22:03 GMT -5
Delisting isn't really a concern right now. What we are worried about is perceptions, and what management was thinking, and what they are doing. The odds of surviving 6 months, with what we know today, I figure to be 10%. Management needs to speak to change that perception, otherwise Shorts and going to continue to dominate (and rightly so). When I listened to the last CC, I heard defeat in their voices. Shorts listened to the call, and smelled blood in the water. Sharks have very good senses... and they are swarming. Unless you have a really big spear, don't jump in the water. MNKD has reduced my spear to a toothpick... |
|
|
|
Post by seanismorris on Mar 6, 2017 14:28:22 GMT -5
I agree on the "Start Now".
The problem is I was screaming ---- START NOW, START NOW, START NOW ----6 months ago.
The Pediatric trial and the Label delays are perfect examples of this...
I don't get what management is thinking... But what I'm thinking, is MannKind is FUBAR because of it's management.
The only reason I'm still here is because I still think Afrezza is a GREAT product. And, I'm sad because it may become nothing more than a footnote.
|
|
